期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

头孢洛林酯抗革兰阳性耐药菌应用研究进展 被引量：1

下载PDF
导出
摘要 目的探讨抗革兰阳性耐药菌新型头孢菌素的研究进展。方法收集国外相关文献,对头孢洛林酯的化学结构、作用机制、抗菌活性、药效学、药动学、临床应用和不良反应进行分析和总结。结果与结论头孢洛林酯对革兰阳性耐药菌具有良好的抗菌活性,具有很好的应用前景。
作者 麦智艺 罗军强 黄文珍 成明建
机构地区 广东省云浮市人民医院药学部
出处 《中国药业》 CAS 2014年第19期123-124,共2页 China Pharmaceuticals
关键词 头孢洛林酯 抗革兰阳性耐药菌 急性细菌性皮肤组织感染 社区获得性细菌性肺炎
分类号 R978.11 [医药卫生—药品] R915 [医药卫生—微生物与生化药学]
  • 相关文献

参考文献16

  • 1Farrell D J, Flamm RK, Sader HS, et al. Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft - tissue infections in Europe (2010) [J]. Int J Antimicrob Agents, 2013,41 (4): 337 - 342.
  • 2Lodise TP, Low DE. Ceftaroline fosamil in the treatment of community acquired bacterial pneumonia and acute bacterial skin and skin structure infections [ J ]. Drugs, 2012,72 ( 11 ) : 1 473 - 1 493.
  • 3Saravolatz LD, Stein GE, Johnson LB. Ceftaroline: a novel cephalosporin with activity against methlciilin -resistant Staphylococcus aureus[J ]. Clin Infect Dis,2011,52(9): 1 156- 1 163.
  • 4McGee L, Biek D, Ge Y, et al. In vitro evaluation of the antimicrobial activ- ity of ceftaroline against cephalosporin - resistant isolates of Streptococcus pneumoniae[J]. Antimicrob Agents Chemother,2009,53 (2): 552 -556.
  • 5Ge Y, Biek D, Talbot GH, et al. In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States [ J ]. Antimicrob Agents Chemother, 2008,52 (9) : 3 398 - 3 407.
  • 6Saravolatz L, Pawlak J, Johnson L. In vitro activity of ceftaroline against community - associated methicillin - resistant, vancomycin - intermediate, vancomycin - resistant, and daptomycin - nonsusceptiblc Staphylococcus au- reus isolates[J]. Antimicrob Agents Chemother,2010,54(7): 3 027 - 3 030. Citron DM, Tyrrell KL, Merriam CV, et al. In vitro activity of ceftaroline a- gainst 623 diverse strains.
  • 7of anaerobic bacteria[J] . Antimicrob Agents Chemother,2010 .54(4): 1 627 - 1 632.
  • 8Jacqueline C, Caillon J, Le Mabecque V, et al. In vivo efficacy of ceftaro- line (PPI- 0903), a new broad- spectrum cephalosporin, compared with linezolid and vancomycin against methicillin - resistant and vancomycin - intermediate Staphylococcus aureus in a rabbit endocarditis model[J]. Antimicrob Agents Chemother, 2007,51 (9): 3 397 - 3 400.
  • 9Jaequeline C, Caillon J, Le Mabecque V, et al. In vivo activity of a novel anti- methieillin- resistant Staphylococcus aureus cephalosporin, cef- taroline, against vancomycin- susceptible and -resistant Enterococcus faecalis strains in a rabbit endocarditis model: a comparative study with linezolid and vancomycin[J]. Antimicrob Agents Chemother,2009,53 ( 12): 5 300 - 5 302.
  • 10Jacqueline C, Amador G, Caillon J, et al. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin - resistant Staphy- lococcus aureus acute osteomyelitis [ J ]. J Antimicrob Chemother, 2010, 65(8): 1 749 - 1 752.

同被引文献9

引证文献1

中国药业
2014年 第19期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部